Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1974-08-29
1976-10-19
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
2523011R, 260429R, A61K 4300, A61K 2900
Patent
active
039871576
ABSTRACT:
A method of preparing improved technetium-99m labeled radiodiagnostic agents by reducing technetium-99m with stannous tartrate. Such radiodiagnostic agents are useful in scintigraphic examinations of the bone and lung.
REFERENCES:
patent: 3735001 (1973-05-01), McRae et al.
patent: 3852414 (1974-12-01), Adler et al.
Gwyther et al., International Journal of Applied Radiation and Isotopes, vol. 17, Aug. 1966, pp. 485-486.
Subramanian et al., Radiology, vol. 102, Mar. 1972, pp. 701-704.
Castronova, Jr., et al., Journal of Nuclear Mediane, vol. 13, No. 11, 1972, pp. 823-827.
Molinski Victor J.
Wilczewski Joseph A.
Blum Israel
Nucker Christine M.
Padgett Benjamin R.
Union Carbide Corporation
LandOfFree
Technetium 99-M labeled radio-diagnostic agents employing stanno does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Technetium 99-M labeled radio-diagnostic agents employing stanno, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Technetium 99-M labeled radio-diagnostic agents employing stanno will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-102820